Paul Tudor Jones’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Paul Tudor Jones’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-300,000	Closed	-$4.93M	–	2914
2023 Q4	$4.93M	Buy	+300,000	New	+$4.72M	0.04%	648

Paul Tudor Jones's ORTX Position: Q1 2024 in Review

Paul Tudor Jones sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 300,000 shares — an estimated $4.93M sold.

Paul Tudor Jones first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $4.93M in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Paul Tudor Jones reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Paul Tudor Jones sold 300,000 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $4.93M.
Paul Tudor Jones first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
Paul Tudor Jones's Orchard Therapeutics plc American Depositary Shares position peaked at $4.93M in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Tudor Investment Corp's 13F filing for Q1 2024, filed 15 May 2024.